Author

T Vanassche

Institution: Universitair Ziekenhuis Leuven

Observed institution: Universitair Ziekenhuis Leuven

OpenAlex ID: A5159739793

Predicted change in 10-year cardiovascular risk one year after initiation of bempedoic acid-based therapy in the MILOS study

2026 · K G Parhofer, M Averna, et al. · European Heart Journal

Real-world use of bempedoic acid in women and men: pooled 1-year follow-up data from the observational, prospective, real-world MILOS study in Austria, Belgium, Germany, Italy, and the United Kingdom

2026 · I Gouni-Berthold, M Averna, et al. · European Heart Journal

Cardiovascular risk and disease in haemophilia a patients: the comor-HA cohort study

2026 · M Erard, L Bommarez, et al. · European Heart Journal

Bempedoic acid for LDL-cholesterol management in patients with and without diabetes: insights from the MILOS study

2026 · T Stulnig, M Averna, et al. · European Heart Journal

Works count: 4

Citation count:

H-index:

I10-index: